CC
CCLD
CareCloud, Inc.
$2.33
-0.64%
$99.4M
No data for this timeframe.
Vol
Market Cap$99.4M
Cap SizeMicro Cap
Inst. Holders7 funds
Inst. Value$7.3M
Inst. Activity2 buys / 2 sells
SEC Reports2
Recent Activity
May 15, 2026
Insider
ROTH NORMAN sold 6,500 shares
Interim CFO and Controller @ $25.25 ($164.1K)
May 15, 2026
Insider
Chaudhry A Hadi sold 7,800 shares
Chief Strategy Officer @ $25.25 ($196.9K)
May 15, 2026
Insider
KORN BILL sold 10,800 shares
Director @ $25.25 ($272.7K)
May 7, 2026
earnings_calendar
CCLD Q1 2026 Earnings Scheduled — 2026-05-07
Apr 16, 2026
SEC
CareCloud reaffirmed prior guidance after closing a $50M credit facility and redeeming all Series B Preferred Stock, but
PRESS-RELEASE — Impact 6/10
Mar 12, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
8-K — Impact 3/10
Inst.
VANGUARD GROUP INC — ADD
1,664,714 shares ($4.9M)
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
446,030 shares ($1.3M)
Price Targets
Historical data — last covering-analyst action Mar 2025. No current recommendation available.
$6.13 (Mar 2025)
Current $2.33
Low $2.50
Median $7.00
High $8.00
4 analysts
$2.50
$8.00
Analyst Ratings
2Strong Buy
4Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 14, 2025 | Roth MKM | REITERATE | Neutral → Neutral |
| Nov 15, 2024 | Benchmark | REITERATE | Buy → Buy |
| May 16, 2024 | Benchmark | MAINTAIN | Buy → Buy |
| Mar 25, 2024 | Benchmark | REITERATE | Buy → Buy |
| Mar 22, 2024 | Maxim Group | UPGRADE | Hold → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.06 ▼ -36.7% | $0.05 — $0.09 | -10% YoY | 3 |
| Next Q | $0.10 ▲ +57.9% | $0.07 — $0.12 | 150% YoY | 3 |
| Current FY | $0.37 ▼ -0.9% | $0.33 — $0.39 | 8% YoY | 3 |
| Next FY | $0.29 ▲ +6.7% | $0.27 — $0.33 | 56% YoY | 3 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $4.9M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $1.3M | ADD |
| WELLS FARGO & COMPANY/MN | $397.1K | DOUBLED |
| TWO SIGMA INVESTMENTS, LP | $261.8K | TRIM |
| BANK OF AMERICA CORP | $259.0K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 15, 2026 | ROTH NORMAN | D | $164.1K |
| May 15, 2026 | Chaudhry A | D | $196.9K |
| May 15, 2026 | KORN BILL | D | $272.7K |
| May 15, 2026 | SNYDER STEPHEN | D | $777.4K |
| Feb 8, 2026 | BUSQUET ANNE | M | $0.00 |
7 institutional holders with $7.3M total value (2,484,675 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,664,714 | $4.9M | 67.0% | ADD +41.3% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 446,030 | $1.3M | 18.0% | ADD +96.1% |
| 3 | WELLS FARGO & COMPANY/MN | 136,000 | $397.1K | 5.5% | DOUBLED +279.6% |
| 4 | TWO SIGMA INVESTMENTS, LP | 89,662 | $261.8K | 3.6% | TRIM -52.2% |
| 5 | BANK OF AMERICA CORP /DE/ | 88,705 | $259.0K | 3.6% | — |
| 6 | MORGAN STANLEY | 59,053 | $172.4K | 2.4% | TRIM -37.6% |
| 7 | FMR LLC | 511 | $1.5K | 0.0% | TRIM -73.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 1,178,296 | 1,664,714 | +41.3% | $4.9M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 227,500 | 446,030 | +96.1% | $1.3M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 187,575 | 89,662 | -52.2% | $261.8K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 94,697 | 59,053 | -37.6% | $172.4K | 2025-Q4 |
| VANGUARD GROUP INC | TRIM | 2,585,290 | 1,178,296 | -54.4% | $3.8M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 143,300 | 227,500 | +58.8% | $730.3K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 144,192 | 187,575 | +30.1% | $602.1K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 191,508 | 94,697 | -50.6% | $304.0K | 2025-Q3 |
| UBS Group AG | TRIM | 90,670 | 32,656 | -64.0% | $104.8K | 2025-Q3 |
| VANGUARD GROUP INC | DOUBLED | 425,101 | 2,585,290 | +508.2% | $6.1M | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 10,795 | 191,508 | +1674.0% | $452.0K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 34,770 | 132,001 | +279.6% | $311.5K | 2025-Q2 |
| UBS Group AG | DOUBLED | 3,228 | 90,670 | +2708.9% | $214.0K | 2025-Q2 |
| FMR LLC | TRIM | 1,900 | 511 | -73.1% | $1.2K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 23,093 | 120,091 | +420.0% | $166.9K | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | ADD | 25,000 | 34,770 | +39.1% | $48.3K | 2025-Q1 |
| CITADEL ADVISORS LLC | NEAR_EXIT | 97,055 | 22,600 | -76.7% | $31.4K | 2025-Q1 |
| MORGAN STANLEY | ADD | 8,341 | 10,795 | +29.4% | $15.0K | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 19,765 | 3,228 | -83.7% | $4.5K | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 50,654 | 97,055 | +91.6% | $355.2K | 2024-Q4 |
| UBS Group AG | DOUBLED | 2,956 | 19,765 | +568.6% | $72.3K | 2024-Q4 |
| MORGAN STANLEY | NEW | — | 8,341 | — | $30.5K | 2024-Q4 |
7 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 15, 2026 | ROTH NORMAN | Interim CFO and Controller | D | 6,500 | $25.25 | $164.1K |
| May 15, 2026 | Chaudhry A Hadi | Chief Strategy Officer | D | 7,800 | $25.25 | $196.9K |
| May 15, 2026 | KORN BILL | Director | D | 10,800 | $25.25 | $272.7K |
| May 15, 2026 | SNYDER STEPHEN ANDREW | Chief Executive Officer | D | 30,790 | $25.25 | $777.4K |
| Feb 8, 2026 | BUSQUET ANNE | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | BUSQUET ANNE | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | KORN BILL | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | KORN BILL | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | MUNTER CAMERON | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | MUNTER CAMERON | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | Sharnak Lawrence Steven | Director | M | 7,500 | $0.00 | $0.00 |
| Feb 8, 2026 | Sharnak Lawrence Steven | Director | M | 7,500 | $0.00 | $0.00 |
| Jan 31, 2026 | MUNTER CAMERON | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | MUNTER CAMERON | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | Sharnak Lawrence Steven | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | Sharnak Lawrence Steven | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | KORN BILL | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | KORN BILL | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | BUSQUET ANNE | Director | M | 6,250 | $0.00 | $0.00 |
| Jan 31, 2026 | BUSQUET ANNE | Director | M | 6,250 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2025): 75% buy across 8 analysts — 2 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Mar 2025. No current recommendation available.
$6.13 mean target (Mar 2025)
$2.50 Low
$8.00 High
| Metric | Value |
|---|---|
| Current Price | $2.33 |
| Target Low | $2.50 |
| Target Mean | $6.13 |
| Target Median | $7.00 |
| Target High | $8.00 |
| # Analysts | 4 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.06 | $0.05 | $0.09 | -9.5% | -36.7% | 0↑ 2↓ | $0.0B | 16.3% | 3 |
| Next Q 2026-09-30 |
$0.10 | $0.07 | $0.12 | 150.0% | +57.9% | 3↑ 0↓ | $0.0B | 10.8% | 3 |
| Current FY 2026-12-31 |
$0.37 | $0.33 | $0.39 | 7.8% | -0.9% | 1↑ 1↓ | $0.1B | 8.7% | 3 |
| Next FY 2027-12-31 |
$0.29 | $0.27 | $0.33 | 56.4% | +6.7% | 2↑ 0↓ | $0.1B | 7.6% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.063 | |
| 7d ago | $0.093 | -0.030 |
| 30d ago | $0.100 | -0.037 |
| 60d ago | $0.090 | -0.027 |
| 90d ago | $0.090 | -0.027 |
5 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 14, 2025 | Roth MKM | REITERATE | Neutral | Neutral |
| Nov 15, 2024 | Benchmark | REITERATE | Buy | Buy |
| May 16, 2024 | Benchmark | MAINTAIN | Buy | Buy |
| Mar 25, 2024 | Benchmark | REITERATE | Buy | Buy |
| Mar 22, 2024 | Maxim Group | UPGRADE | Hold | Buy |
| Nov 16, 2023 | Benchmark | REITERATE | Buy | Buy |
| Aug 4, 2023 | Roth MKM | DOWNGRADE | Buy | Neutral |
| May 5, 2023 | EF Hutton | REITERATE | — | Buy |
| Mar 20, 2023 | EF Hutton | INITIATE | — | Buy |
| Mar 3, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jan 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
CCLD Q1 2026 Earnings Scheduled — 2026-05-07
Apr 16, 2026
earnings
CareCloud Reaffirms Guidance Following Capital Structure Simplification, Capping a Decade of Transformation
<p align="justify"><strong>SOMERSET, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- </strong>CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Co
Apr 6, 2026
other
Arkansas Otolaryngology Center Selects CareCloud to Power Next-Level Practice Management and Revenue Optimization with AI-Enabled Solutions
<p align="justify"><strong>SOMERSET, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- </strong>CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Co
Mar 12, 2026
earnings_calendar
CCLD Q4 2025 Earnings After Market Close — 2026-03-12